BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gholamin S, Youssef OA, Rafat M, et al. (2019) Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immunity. 1753425919876690
Hutter G, Theruvath J, Graef CM, et al. (2019) Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America
Kahn SA, Wang X, Nitta RT, et al. (2018) Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4651
Kahn SA, Wang X, Nitta RT, et al. (2018) Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121
Purzner T, Purzner J, Buckstaff T, et al. (2018) Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science Signaling. 11
Gholamin S, Mitra SS, Feroze AH, et al. (2017) Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9
Chang J, Mancuso MR, Maier C, et al. (2017) Gpr124 is essential for blood-brain barrier integrity in central nervous system disease. Nature Medicine
Assad Kahn S, Costa SL, Gholamin S, et al. (2016) The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway. Embo Molecular Medicine. 8: 511-526
Zhang M, Hutter G, Kahn SA, et al. (2016) Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. Plos One. 11: e0153550
Razavi SM, Lee KE, Jin BE, et al. (2016) Immune Evasion Strategies of Glioblastoma. Frontiers in Surgery. 3: 11
See more...